Kairi brown 
Monkeypox: EU approves vaccine to combat outbreak
The European Commission approved the Imvanex Bavaria Nordic vaccine – which protects against smallpox – to be used against Monkeypox in the EU, the Biotek Denmark company said on Monday.
Bavarian Nordic said the agreement came after “positive opinion” from the Medicinal Product Committee for Human Use (CHMP) last week, and applies in all EU member countries.
The availability of approved vaccines can significantly increase the readiness of countries to fight diseases that arise, but only through investment and structured planning from biological preparedness,” said Bavaria Executive Chief Nordic Paul Chaplin.
The announcement occurred a day after the World Health Organization (WHO) declared the Monkeypox outbreak as a global health emergency.
Chaplin told the Reuters news agency that the company was also in talks to potentially foster production capacity and could meet the demand for the Monkeypox vaccine in tens of millions.
What we know about the imvanex vaccine
Imvanex is the only vaccine that has been given approval for the prevention of monkeypox in the United States and Canada and previously only approved for use in smallpox treatment.
According to Bavaria Nordic, the jab is “non -replication smallpox vaccine” developed in collaboration with the US government.
IMVAnex development is possible through significant investments from the US government over the past two decades,” said the company.
Bavarian Nordic’s share price has increased by 122% over the past three months, driven by strong demand for vaccines to fight Monkeypox.
This disease is endemic in West and Central Africa, but spreads to countries around the world starting in May this year.
Since then, more than 15,300 cases in 75 countries have been confirmed in the laboratory, according to WHO. The outbreak is currently centered in Europe.
What are the symptoms of monkeypox?
According to WHO, those who contract Monkeypox reported high fever, severe headaches and swollen lymph nodes, as well as back pain and muscle pain.
Skin rashes and lesions usually appear 1 to 3 days after the appearance of fever. The rash is most often broken on the face, but can also appear in the palms and soles of the feet.
Most people recovered in a few weeks without requiring medical attention. Monkeypox is similar to smallpox, but less dangerous and less contagious
